Study of BMS-986012 in Subjects With Small Cell Lung Caner

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

NCT05543629 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

NCT00290953 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

NCT00658580 ·Status: COMPLETED ·Phase: PHASE3

Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

NCT02799862 ·Status: COMPLETED

A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan

NCT03273790 ·Status: COMPLETED

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

NCT06698965 ·Status: RECRUITING ·Phase: PHASE2

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

NCT06931145 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

NCT04902885 ·Status: COMPLETED ·Phase: PHASE3

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

NCT07107490 ·Status: RECRUITING ·Phase: PHASE1

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

NCT02179528 ·Status: UNKNOWN ·Phase: PHASE2

Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer

NCT04012606 ·Status: COMPLETED ·Phase: PHASE3

A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan

NCT05161325 ·Status: ACTIVE_NOT_RECRUITING

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

NCT00099879 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

NCT07063745 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

NCT04691063 ·Status: UNKNOWN ·Phase: PHASE3

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

NCT02481830 ·Status: COMPLETED ·Phase: PHASE3

E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00832819 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY2940680 in Small Cell Lung Cancer

NCT01722292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer

NCT07063407 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT06094296 ·Status: TERMINATED ·Phase: PHASE2

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

NCT06646276 ·Status: RECRUITING ·Phase: PHASE3

A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

NCT00927875 ·Status: COMPLETED ·Phase: PHASE1

A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer

NCT00951613 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT05920356 ·Status: RECRUITING ·Phase: PHASE3

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

NCT05005273 ·Status: COMPLETED ·Phase: PHASE2